Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036690 (
sepsis
)
59,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Interleukin 22
(
IL-22
) is a TH17-like cytokine known to specifically activate epithelial cells, thereby strengthening immune defense at host/environment interfaces. Animal studies suggest that
IL-22
may play a crucial role in clinical
sepsis
. However, little is known about
IL-22
in
sepsis
patients. In a single-center university hospital setting, serum
IL-22
levels were assessed in 16 patients with the diagnosis of abdominal
sepsis
, 16 patients who have undergone elective major abdominal surgery without the diagnosis of
sepsis
, and 21 healthy volunteers. In accordance with current knowledge, we observed enhanced levels of IL-6 and IL-10 in serum specimens of
sepsis
patients compared with surgical control patients. Here, we report, for the first time, a modest but significant elevation of serum
IL-22
detectable in abdominal
sepsis
patients (P G 0.001). Median serum concentrations of
IL-22
were 111.8 pg/mL, 3.4 or 2.0 pg/mL, and 9.3 pg/mL for abdominal
sepsis
patients, surgical control patients (presurgery or postsurgery), and healthy volunteers,respectively.
Interleukin 22
produced in the course of abdominal
sepsis
may contribute to host defense and stabilization of mucosal barrier functions under conditions of systemic infection.
...
PMID:Interleukin-22 detected in patients with abdominal sepsis. 2022 May 64